Defective neuritogenesis is a contributing pathogenic mechanism underlying a variety of neurodevelopmental disorders. Single gene mutations in activity-dependent neuroprotective protein (ADNP) are the most frequent among autism spectrum disorders (ASDs) leading to the ADNP syndrome. Previous studies showed that during neuritogenesis, Adnp localizes to the cytoplasm/neurites, and Adnp knockdown inhibits neuritogenesis in culture. Here, we hypothesized that Adnp is localized in the cytoplasm during neurite formation and that this process is mediated by 14-3-3. Indeed, applying the 14-3-3 inhibitor, difopein, blocked Adnp cytoplasmic localization. Furthermore, co-immunoprecipitations showed that Adnp bound 14-3-3 proteins and proteomic analysis identified several potential phosphorylation-dependent Adnp/14-3-3 binding sites. We further discovered that knockdown of Adnp using in utero electroporation of mouse layer 2/3 pyramidal neurons in the somatosensory cortex led to previously unreported changes in neurite formation beginning at P0. Defects were sustained throughout development, the most notable included increased basal dendrite number and axon length. Paralleling the observed morphological aberrations, ex vivo calcium imaging revealed that Adnp deficient neurons had greater and more frequent spontaneous calcium influx in female mice. GRAPHIC, a novel synaptic tracing technology substantiated this finding, revealing increased interhemispheric connectivity between female Adnp deficient layer 2/3 pyramidal neurons. We conclude that Adnp is localized to the cytoplasm by 14-3-3 proteins, where it regulates neurite formation, maturation, and functional cortical connectivity significantly building on our current understanding of Adnp function and the etiology of ADNP syndrome.
This is a preview of subscription content, access via your institution
Open Access articles citing this article.
Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism
Clinical Epigenetics Open Access 21 March 2023
Subscribe to this journal
Receive 12 print issues and online access
$259.00 per year
only $21.58 per issue
Rent or buy this article
Get just this article for as long as you need it
Prices may be subject to local taxes which are calculated during checkout
Reese D, Drapeau P. Neurite growth patterns leading to functional synapses in an identified embryonic neuron. J Neurosci: Off J Soc Neurosci. 1998;18:5652–62.
Yi G, Wang J, Wei X, Deng B. Dendritic properties control energy efficiency of action potentials in cortical pyramidal cells. Front Cell Neurosci. 2017;11:265.
Bradke F, Dotti CG. Establishment of neuronal polarity: Lessons from cultured hippocampal neurons. Curr Opin Neurobiol. 2000;10:574–81.
da Silva JS, Dotti CG. Breaking the neuronal sphere: Regulation of the actin cytoskeleton in neuritogenesis. Nat Rev Neurosci. 2002;3:694–704.
Dotti CG, Sullivan CA, Banker GA. The establishment of polarity by hippocampal neurons in culture. J Neurosci: Off J Soc Neurosci. 1988;8:1454–68.
Craig AM, Banker G. Neuronal polarity. Annu Rev Neurosci. 1994;17:267–310.
Bennison SA, Blazejewski SM, Smith TH, Toyo-Oka K. Protein kinases: Master regulators of neuritogenesis and therapeutic targets for axon regeneration. Cell Mol life Sci: CMLS. 2019;77:1511–30.
Cornell B, Wachi T, Zhukarev V, Toyo-Oka K. Regulation of neuronal morphogenesis by 14-3-3epsilon (Ywhae) via the microtubule binding protein, doublecortin. Hum Mol Genet. 2016;25:4405–18.
Zhang S-X, Duan L-H, Qian H, Yu X. Actin aggregations mark the sites of neurite initiation. Neurosci Bull. 2016;32:1–15.
Zhang S-X, Duan L-H, He S-J, Zhuang G-F, Yu X. Phosphatidylinositol 3,4-bisphosphate regulates neurite initiation and dendrite morphogenesis via actin aggregation. Cell Res. 2017;27:253–73.
Dehmelt L, Halpain S. Actin and microtubules in neurite initiation: Are MAPs the missing link? J Neurobiol. 2004;58:18–33.
Dehmelt L, Nalbant P, Steffen W, Halpain S. A microtubule-based, dynein-dependent force induces local cell protrusions: Implications for neurite initiation. Brain Cell Biol. 2006;35:39–56.
Flynn KC. The cytoskeleton and neurite initiation. Bioarchitecture. 2013;3:86–109.
Lu W, Fox P, Lakonishok M, Davidson MW, Gelfand VI. Initial neurite outgrowth in Drosophila neurons is driven by kinesin-powered microtubule sliding. Curr Biol: CB. 2013;23:1018–23.
Hausser M, Spruston N, Stuart GJ. Diversity and dynamics of dendritic signaling. Science (NY). 2000;290:739–44.
Gipson CD, Olive MF. Structural and functional plasticity of dendritic spines - root or result of behavior? Genes Brain Behav. 2017;16:101–17.
Yuste R, Denk W. Dendritic spines as basic functional units of neuronal integration. Nature. 1995;375:682–4.
Ozeki Y, Tomoda T, Kleiderlein J, Kamiya A, Bord L, Fujii K, et al. Disrupted-in-Schizophrenia-1 (DISC-1): mutant truncation prevents binding to NudE-like (NUDEL) and inhibits neurite outgrowth. Proc Natl Acad Sci USA. 2003;100:289–94.
Murtomaki S, Risteli J, Risteli L, Koivisto UM, Johansson S, Liesi P. Laminin and its neurite outgrowth-promoting domain in the brain in Alzheimer’s disease and Down’s syndrome patients. J Neurosci Res. 1992;32:261–73.
Bakos J, Bacova Z, Grant SG, Castejon AM, Ostatnikova D. Are Molecules Involved in Neuritogenesis and Axon Guidance Related to Autism Pathogenesis? Neuromolecular Med. 2015;17:297–304.
Lepagnol-Bestel AM, Maussion G, Boda B, Cardona A, Iwayama Y, Delezoide AL, et al. SLC25A12 expression is associated with neurite outgrowth and is upregulated in the prefrontal cortex of autistic subjects. Mol Psychiatry. 2008;13:385–97.
Gozes I. Activity-dependent neuroprotective protein: From gene to drug candidate. Pharmacol therapeutics. 2007;114:146–54.
Van Dijck A, Vulto-van Silfhout AT, Cappuyns E, van der Werf IM, Mancini GM, Tzschach A. et al. Clinical presentation of a complex neurodevelopmental disorder caused by mutations in ADNP. Biol Psychiatry. 2019;85:287–97.
Levine J, Cohen D, Herman C, Verloes A, Guinchat V, Diaz L, et al. Developmental phenotype of the rare case of DJ caused by a unique ADNP gene de novo mutation. J Mol Neurosci: MN. 2019;68:321–30.
Ivashko-Pachima Y, Hadar A, Grigg I, Korenková V, Kapitansky O, Karmon G, et al. Discovery of autism/intellectual disability somatic mutations in Alzheimer’s brains: mutated ADNP cytoskeletal impairments and repair as a case study. Mol Psychiatry. 2021;26:1619–33.
Gozes I, Van Dijck A, Hacohen-Kleiman G, Grigg I, Karmon G, Giladi E, et al. Premature primary tooth eruption in cognitive/motor-delayed ADNP-mutated children. Transl Psychiatry. 2017;7:e1166.
Gozes I, Patterson MC, Van Dijck A, Kooy RF, Peeden JN, Eichenberger JA, et al. The eight and a half year journey of undiagnosed AD: Gene sequencing and funding of advanced genetic testing has led to hope and new beginnings. Front Endocrinol. 2017;8:107.
Gozes I, Helsmoortel C, Vandeweyer G, Van der Aa N, Kooy F, Bedrosian-Sermone S. The compassionate side of neuroscience: Tony Sermone’s undiagnosed genetic journey-ADNP mutation. J Mol Neurosci: MN. 2015;56:751–7.
Vulih-Shultzman I, Pinhasov A, Mandel S, Grigoriadis N, Touloumi O, Pittel Z, et al. Activity-dependent neuroprotective protein snippet NAP reduces tau hyperphosphorylation and enhances learning in a novel transgenic mouse model. J Pharm Exp Ther. 2007;323:438–49.
Gozes I. The ADNP Syndrome and CP201 (NAP) Potential and Hope. Front Neurol. 2020;11:608444.
Pascual M, Guerri C. The peptide NAP promotes neuronal growth and differentiation through extracellular signal-regulated protein kinase and Akt pathways, and protects neurons co-cultured with astrocytes damaged by ethanol. J Neurochem. 2007;103:557–68.
Smith-Swintosky VL, Gozes I, Brenneman DE, D’Andrea MR, Plata-Salaman CR. Activity-dependent neurotrophic factor-9 and NAP promote neurite outgrowth in rat hippocampal and cortical cultures. J Mol Neurosci: MN. 2005;25:225–38.
Ivashko-Pachima Y, Sayas CL, Malishkevich A, Gozes I. ADNP/NAP dramatically increase microtubule end-binding protein-Tau interaction: a novel avenue for protection against tauopathy. Mol psychiatry. 2017;22:1335–44.
Ivashko-Pachima Y, Maor-Nof M, Gozes I. NAP (davunetide) preferential interaction with dynamic 3-repeat Tau explains differential protection in selected tauopathies. PloS one. 2019;14:e0213666.
Hacohen-Kleiman G, Sragovich S, Karmon G, Gao AYL, Grigg I, Pasmanik-Chor M, et al. Activity-dependent neuroprotective protein deficiency models synaptic and developmental phenotypes of autism-like syndrome. J Clin Investig. 2018;128:4956–69.
Oz S, Kapitansky O, Ivashco-Pachima Y, Malishkevich A, Giladi E, Skalka N, et al. The NAP motif of activity-dependent neuroprotective protein (ADNP) regulates dendritic spines through microtubule end binding proteins. Mol psychiatry. 2014;19:1115–24.
Magen I, Gozes I. Microtubule-stabilizing peptides and small molecules protecting axonal transport and brain function: focus on davunetide (NAP). Neuropeptides. 2013;47:489–95.
Sun X, Peng X, Cao Y, Zhou Y, Sun Y. ADNP promotes neural differentiation by modulating Wnt/β-catenin signaling. Nat Commun. 2020;11:2984.
Mandel S, Spivak-Pohis I, Gozes I. ADNP differential nucleus/cytoplasm localization in neurons suggests multiple roles in neuronal differentiation and maintenance. J Mol Neurosci: MN. 2008;35:127–41.
Blazejewski SM, Bennison SA, Ha NT, Liu X, Smith TH, Dougherty KJ, et al. Rpsa signaling regulates cortical neuronal morphogenesis via its ligand, PEDF, and plasma membrane interaction partner, Itga6. Cereb Cortex. 2021;32:770–95.
Liu X, Blazejewski SM, Bennison SA, Toyo-Oka K. Glutathione S-transferase Pi (Gstp) proteins regulate neuritogenesis in the developing cerebral cortex. Hum Mol Genet. 2021;30:30–45.
Hacohen-Kleiman G, Yizhar-Barnea O, Touloumi O, Lagoudaki R, Avraham KB, Grigoriadis N, et al. Atypical auditory brainstem response and protein expression aberrations related to ASD and hearing loss in the Adnp haploinsufficient mouse brain. Neurochem Res. 2019;44:1494–507.
Malishkevich A, Amram N, Hacohen-Kleiman G, Magen I, Giladi E, Gozes I. Activity-dependent neuroprotective protein (ADNP) exhibits striking sexual dichotomy impacting on autistic and Alzheimer’s pathologies. Transl Psychiatry. 2015;5:e501.
Amram N, Hacohen-Kleiman G, Sragovich S, Malishkevich A, Katz J, Touloumi O, et al. Sexual divergence in microtubule function: the novel intranasal microtubule targeting SKIP normalizes axonal transport and enhances memory. Mol psychiatry. 2016;21:1467–76.
Wachi T, Cornell B, Marshall C, Zhukarev V, Baas PW, Toyo-oka K. Ablation of the 14-3-3gamma protein results in neuronal migration delay and morphological defects in the developing cerebral cortex. Dev Neurobiol. 2016;76:600–14.
Cornell B, Wachi T, Zhukarev V, Toyo-Oka K. Overexpression of the 14-3-3gamma protein in embryonic mice results in neuronal migration delay in the developing cerebral cortex. Neurosci Lett. 2016;628:40–46.
Risher WC, Ustunkaya T, Singh Alvarado J, Eroglu C. Rapid Golgi analysis method for efficient and unbiased classification of dendritic spines. PloS one. 2014;9:e107591.
Chen T-W, Wardill TJ, Sun Y, Pulver SR, Renninger SL, Baohan A, et al. Ultra-sensitive fluorescent proteins for imaging neuronal activity. Nature. 2013;499:295–300.
Blazejewski SM, Bennison SA, Liu X, Toyo-Oka K. High-throughput kinase inhibitor screening reveals roles for Aurora and Nuak kinases in neurite initiation and dendritic branching. Sci Rep. 2021;11:8156.
Mandel S, Gozes I. Activity-dependent neuroprotective protein constitutes a novel element in the SWI/SNF chromatin remodeling complex. J Biol Chem. 2007;282:34448–56.
Mandel S, Rechavi G, Gozes I. Activity-dependent neuroprotective protein (ADNP) differentially interacts with chromatin to regulate genes essential for embryogenesis. Developmental Biol. 2007;303:814–24.
Oz S, Ivashko-Pachima Y, Gozes I. The ADNP derived peptide, NAP modulates the tubulin pool: implication for neurotrophic and neuroprotective activities. PloS one. 2012;7:51458–51458.
Cornell B, Toyo-Oka K. 14-3-3 proteins in brain development: Neurogenesis, neuronal migration and neuromorphogenesis. Front Mol Neurosci. 2017;10:318.
Johnson C, Crowther S, Stafford MJ, Campbell DG, Toth R, MacKintosh C. Bioinformatic and experimental survey of 14-3-3-binding sites. Biochemical J. 2010;427:69–78.
Mao AJ, Bechberger J, Lidington D, Galipeau J, Laird DW, Naus CC. Neuronal differentiation and growth control of neuro-2a cells after retroviral gene delivery of connexin43. J Biol Chem. 2000;275:34407–14.
Fan S, Ramirez SH, Garcia TM, Dewhurst S. Dishevelled promotes neurite outgrowth in neuronal differentiating neuroblastoma 2A cells, via a DIX-domain dependent pathway. Mol Brain Res. 2004;132:38–50.
Gennet N, Herden C, Bubb VJ, Quinn JP, Kipar A. Expression of activity-dependent neuroprotective protein in the brain of adult rats. Histol Histopathol. 2008;23:309–17.
Bassan M, Zamostiano R, Davidson A, Pinhasov A, Giladi E, Perl O, et al. Complete sequence of a novel protein containing a femtomolar-activity-dependent neuroprotective peptide. J Neurochemistry. 1999;72:1283–93.
Hacohen-Kleiman G, Moaraf S, Kapitansky O, Gozes I. Sex-and region-dependent expression of the autism-linked ADNP correlates with social- and speech-related genes in the canary brain. J Mol Neurosci: MN. 2020;70:1671–83.
Witte H, Bradke F. The role of the cytoskeleton during neuronal polarization. Curr Opin Neurobiol. 2008;18:479–87.
Taniguchi Y, Young-Pearse T, Sawa A, Kamiya A. In utero electroporation as a tool for genetic manipulation in vivo to study psychiatric disorders: from genes to circuits and behaviors. Neuroscientist: a Rev J bringing Neurobiol, Neurol psychiatry. 2012;18:169–79.
Freichel C, Potschka H, Ebert U, Brandt C, Löscher W. Acute changes in the neuronal expression of GABA and glutamate decarboxylase isoforms in the rat piriform cortex following status epilepticus. Neuroscience. 2006;141:2177–94.
Ramı́rez M, Gutiérrez R. Activity-dependent expression of GAD67 in the granule cells of the rat hippocampus. Brain Res. 2001;917:139–46.
Sperk G, Wieselthaler-Hölzl A, Pirker S, Tasan R, Strasser SS, Drexel M, et al. Glutamate decarboxylase 67 is expressed in hippocampal mossy fibers of temporal lobe epilepsy patients. Hippocampus. 2012;22:590–603.
Sarro EC, Kotak VC, Sanes DH, Aoki C. Hearing loss alters the subcellular distribution of presynaptic GAD and postsynaptic GABAA receptors in the auditory cortex. Cereb Cortex. 2008;18:2855–67.
Kinoshita N, Huang AJY, McHugh TJ, Suzuki SC, Masai I, Kim IH, et al. Genetically encoded fluorescent indicator GRAPHIC delineates intercellular connections. iScience. 2019;15:28–38.
Li XS, Wu HT, Yu Y, Chen GY, Qin XY, Zheng GE, et al. Increased serum FGF2 levels in first-episode, drug-free patients with schizophrenia. Neurosci Lett. 2018;686:28–32.
Merenlender-Wagner A, Malishkevich A, Shemer Z, Udawela M, Gibbons A, Scarr E, et al. Autophagy has a key role in the pathophysiology of schizophrenia. Mol psychiatry. 2015;20:126–32.
Malishkevich A, Marshall GA, Schultz AP, Sperling RA, Aharon-Peretz J, Gozes I. Blood-Borne Activity-Dependent Neuroprotective Protein (ADNP) is correlated with premorbid intelligence, clinical stage, and Alzheimer’s disease biomarkers. J Alzheimers Dis. 2016;50:249–60.
Sragovich S, Malishkevich A, Piontkewitz Y, Giladi E, Touloumi O, Lagoudaki R, et al. The autism/neuroprotection-linked ADNP/NAP regulate the excitatory glutamatergic synapse. Transl Psychiatry. 2019;9:2.
Karmon G, Sragovich S, Hacohen-Kleiman G, Ben-Horin-Hazak I, Kasparek P, Schuster B, et al. Novel ADNP syndrome mice reveal dramatic sex-specific peripheral gene expression with brain synaptic and tau pathologies. Biol Psychiatry. 2022;92:81–95.
Grigg I, Ivashko-Pachima Y, Hait TA, Korenková V, Touloumi O, Lagoudaki R, et al. Tauopathy in the young autistic brain: Novel biomarker and therapeutic target. Transl Psychiatry. 2020;10:228.
Routh BN, Rathour RK, Baumgardner ME, Kalmbach BE, Johnston D, Brager DH. Increased transient Na+ conductance and action potential output in layer 2/3 prefrontal cortex neurons of the fmr1−/y mouse. J Physiol. 2017;595:4431–48.
Rane P, Cochran D, Hodge SM, Haselgrove C, Kennedy DN, Frazier JA. Connectivity in autism: A review of MRI connectivity studies. Harv Rev Psychiatry. 2015;23:223–44.
Kast RJ, Levitt P. Precision in the development of neocortical architecture: From progenitors to cortical networks. Prog Neurobiol. 2019;175:77–95.
Pabba M, Scifo E, Kapadia F, Nikolova YS, Ma T, Mechawar N, et al. Resilient protein co-expression network in male orbitofrontal cortex layer 2/3 during human aging. Neurobiol Aging. 2017;58:180–90.
Kitamura S, Shimada H, Niwa F, Endo H, Shinotoh H, Takahata K, et al. Tau-induced focal neurotoxicity and network disruption related to apathy in Alzheimer’s disease. J Neurol, Neurosurg Psychiatry. 2018;89:1208–14.
Ivashko-Pachima Y, Hadar A, Grigg I, Korenková V, Kapitansky O, Karmon G, et al. Discovery of autism/intellectual disability somatic mutations in Alzheimer’s brains: mutated ADNP cytoskeletal impairments and repair as a case study. Mol psychiatry. 2021;26:1619–33.
Zamostiano R, Pinhasov A, Gelber E, Steingart RA, Seroussi E, Giladi E, et al. Cloning and characterization of the human activity-dependent neuroprotective protein. J Biol Chem. 2001;276:708–14.
Cappuyns E, Huyghebaert J, Vandeweyer G, Kooy RF. Mutations in ADNP affect expression and subcellular localization of the protein. Cell Cycle. 2018;17:1068–75.
Brunet A, Kanai F, Stehn J, Xu J, Sarbassova D, Frangioni JV, et al. 14-3-3 transits to the nucleus and participates in dynamic nucleocytoplasmic transport. J Cell Biol. 2002;156:817–28.
Wu YK, Fujishima K, Kengaku M. Differentiation of apical and basal dendrites in pyramidal cells and granule cells in dissociated hippocampal cultures. PloS one. 2015;10:e0118482.
Han YM, Chan AS. Disordered cortical connectivity underlies the executive function deficits in children with autism spectrum disorders. Res Developmental Disabilities. 2017;61:19–31.
Holiga S, Hipp JF, Chatham CH, Garces P, Spooren W, D’Ardhuy XL, et al. Patients with autism spectrum disorders display reproducible functional connectivity alterations. Sci Transl Med. 2019;11:eaat9223.
Bhat AN, McDonald NM, Eilbott JE, Pelphrey KA. Exploring cortical activation and connectivity in infants with and without familial risk for autism during naturalistic social interactions: A preliminary study. Infant Behav Dev. 2019;57:101337.
Takarae Y, Sweeney J. Neural Hyperexcitability in Autism Spectrum Disorders. Brain Sci. 2017;7:129.
Hutsler JJ, Casanova MF. Review: Cortical construction in autism spectrum disorder: columns, connectivity and the subplate. Neuropathol Appl Neurobiol. 2016;42:115–34.
Kapitansky O, Karmon G, Sragovich S, Hadar A, Shahoha M, Jaljuli I, et al. Single Cell ADNP Predictive of Human Muscle Disorders: Mouse Knockdown Results in Muscle Wasting. Cells. 2020;9:2320.
Helsmoortel C, Vulto-van Silfhout AT, Coe BP, Vandeweyer G, Rooms L, van den Ende J, et al. A SWI/SNF-related autism syndrome caused by de novo mutations in ADNP. Nat Genet. 2014;46:380–4.
We would like to thank Dr. Peter Baas, Dr. Wen-Jun Gao, Dr. Elias Spiliotis, and Dr. Pat Levitt for their helpful comments, feedback, and fruitful discussions on this manuscript. We further thank Dr. Paschalis Theotokis for retrieval of results from ADNP mice and Dr. Tomomi Shimogori in Riken Center for Brain Science in Japan who provided the GRAPHIC vectors. This work has been supported by a research grant from the NINDS (R01NS096098-01A1 to KT and F31NS113404-01A1 to SMB), the NICHD (F31HD103405-01A1 to SAB), ERA-NET Neuron (ADNPinMED), Drs. Ronith and Armand Stemmer and Arthur Gerbi (French Friends of Tel Aviv University), Anne and Alex Cohen (Canadian Friends of Tel Aviv University) and Holly and Jonathan Strelzik (American Friends of Tel Aviv University) (IG).
NAP (CP201, davunetide) use is under patent protection (US patent nos. US7960334, US8618043, US10912819 and WO2017130190A1) (IG), PCT/IL2020/051010 (IG) and provisional patent applications have been submitted (IG inventor and contributing scientist SS). Davunetide is exclusively licensed to ATED Therapeutics LTD (IG, Co-Founder and Chief Scientific Officer).
Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.
Rights and permissions
Springer Nature or its licensor (e.g. a society or other partner) holds exclusive rights to this article under a publishing agreement with the author(s) or other rightsholder(s); author self-archiving of the accepted manuscript version of this article is solely governed by the terms of such publishing agreement and applicable law.
About this article
Cite this article
Bennison, S.A., Blazejewski, S.M., Liu, X. et al. The cytoplasmic localization of ADNP through 14-3-3 promotes sex-dependent neuronal morphogenesis, cortical connectivity, and calcium signaling. Mol Psychiatry (2023). https://doi.org/10.1038/s41380-022-01939-3
This article is cited by
Chromatin remodeler Activity-Dependent Neuroprotective Protein (ADNP) contributes to syndromic autism
Clinical Epigenetics (2023)